100 related articles for article (PubMed ID: 25222251)
1. Association of MLL3 expression with prognosis in gastric cancer.
Li B; Liu HY; Guo SH; Sun P; Gong FM; Jia BQ
Genet Mol Res; 2014 Sep; 13(3):7513-8. PubMed ID: 25222251
[TBL] [Abstract][Full Text] [Related]
2. TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer.
Fujii S; Fujihara A; Natori K; Abe A; Kuboki Y; Higuchi Y; Aizawa M; Kuwata T; Kinoshita T; Yasui W; Ochiai A
Cancer Med; 2015 Nov; 4(11):1667-78. PubMed ID: 26336878
[TBL] [Abstract][Full Text] [Related]
3. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.
Matsukawa Y; Semba S; Kato H; Ito A; Yanagihara K; Yokozaki H
Cancer Sci; 2006 Jun; 97(6):484-91. PubMed ID: 16734726
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ERCC1 expression in peripheral blood lymphocytes with outcomes of patients with gastric cancer treated with oxaliplatin-based adjuvant chemotherapy.
Zhang YY; Gu KS; Wu HY; Yang F; Bu LJ; Zhao CC; Zhang YR
Genet Mol Res; 2015 Dec; 14(4):15921-9. PubMed ID: 26662383
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma.
Zhu Y; Yang W; Ji G; Lin N; Wu W; Xiong P; Zheng C; Yan L; Wan P; Wang Y
Oncotarget; 2017 May; 8(19):31092-31100. PubMed ID: 28415703
[TBL] [Abstract][Full Text] [Related]
8. A missense mutation (S3660L) in MLL3 gene influences risk of gastric cancer.
Li B; Liu HY; Guo SH; Sun P; Gong FM; Jia BQ
J BUON; 2014; 19(2):394-7. PubMed ID: 24965397
[TBL] [Abstract][Full Text] [Related]
9. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
10. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
[TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
[TBL] [Abstract][Full Text] [Related]
13. TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma.
Chen W; Lu C; Hong J
Med Sci Monit; 2018 Nov; 24():8033-8041. PubMed ID: 30412518
[TBL] [Abstract][Full Text] [Related]
14. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
15. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
16. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical implication of S100A12 in gastric carcinoma.
Li D; Zeng Z; Yu T; Qin J; Wu J; Song JC; Zhou ZY; Yuan JP
Tumour Biol; 2016 May; 37(5):6551-9. PubMed ID: 26638166
[TBL] [Abstract][Full Text] [Related]
18. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703
[TBL] [Abstract][Full Text] [Related]
19. Expression of SIP1 is strongly correlated with LDHA and shows a significantly poor outcome in gastric cancer.
Sun X; Sun Z; Zhu Z; Li C; Zhang J; Xu H; Sun M
Tumour Biol; 2015 Sep; 36(10):7521-30. PubMed ID: 25913622
[TBL] [Abstract][Full Text] [Related]
20. Low expression of CD80 predicts for poor prognosis in patients with gastric adenocarcinoma.
Feng XY; Lu L; Wang KF; Zhu BY; Wen XZ; Peng RQ; Ding Y; Li DD; Li JJ; Li Y; Zhang XS
Future Oncol; 2019 Feb; 15(5):473-483. PubMed ID: 30628844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]